Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Multiple drugs: Coronavirus encephalitis: case reportReactions weekly, 2017-10 (1675), p.166-166Auckland: Springer Nature B.VTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Antineoplastics: Middle east respiratory syndrome-coronavirus infection and associated complications: case reportReactions weekly, 2018-02 (1689), p.33-33Auckland: Springer Nature B.VTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Immunosuppressants: various toxicities: case reportReactions weekly, 2020-03 (1795), p.152-152Auckland: Springer Nature B.VTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Global operation targets rise in counterfeit COVID-related medical itemsReactions weekly, 2020-04 (1798), p.2-2Auckland: Springer Nature B.VTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Regulatory agencies issue advice on use of NSAIDs for COVID-19Reactions weekly, 2020-04 (1798), p.3-3Auckland: Springer Nature B.VTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
EMA: continue use of ACE inhibitors, sartans during COVID-19 pandemicReactions weekly, 2020-04 (1799), p.5-5Auckland: Springer Nature B.VTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
High incidence of ADRs in COVID-19 patients in ChinaReactions weekly, 2020-05 (1802), p.7-7Auckland: Springer Nature B.VTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
ACEI inhibitors and ARBs do not increase severity of COVID-19Reactions weekly, 2020-05 (1802), p.5-5Auckland: Springer Nature B.VTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Safety concerns with higher dosage chloroquine in COVID-19 patientsReactions weekly, 2020-05 (1802), p.11-11Auckland: Springer Nature B.VTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Antimalarial use in COVID-19 patients requires close monitoringReactions weekly, 2020-05 (1802), p.1-1Auckland: Springer Nature B.VTexto completo disponível |